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Abstract
The advent of high-throughput sequencing techniques has made it possible to follow the genomic evolution of pathogenic
bacteria by comparing longitudinally collected bacteria sampled from human hosts. Such studies in the context of chronic
airway infections by Pseudomonas aeruginosa in cystic fibrosis (CF) patients have indicated high bacterial population
diversity. Such diversity may be driven by hypermutability resulting from DNA mismatch repair system (MRS) deficiency, a
common trait evolved by P. aeruginosa strains in CF infections. No studies to date have utilized whole-genome sequencing
to investigate within-host population diversity or long-term evolution of mutators in CF airways. We sequenced the
genomes of 13 and 14 isolates of P. aeruginosa mutator populations from an Argentinian and a Danish CF patient,
respectively. Our collection of isolates spanned 6 and 20 years of patient infection history, respectively. We sequenced 11
isolates from a single sample from each patient to allow in-depth analysis of population diversity. Each patient was infected
by clonal populations of bacteria that were dominated by mutators. The in vivo mutation rate of the populations was ,100
SNPs/year–,40-fold higher than rates in normo-mutable populations. Comparison of the genomes of 11 isolates from the
same sample showed extensive within-patient genomic diversification; the populations were composed of different sub-
lineages that had coexisted for many years since the initial colonization of the patient. Analysis of the mutations identified
genes that underwent convergent evolution across lineages and sub-lineages, suggesting that the genes were targeted by
mutation to optimize pathogenic fitness. Parallel evolution was observed in reduction of overall catabolic capacity of the
populations. These findings are useful for understanding the evolution of pathogen populations and identifying new
targets for control of chronic infections.
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Introduction
The opportunistic pathogen Pseudomonas aeruginosa is found
in many environments and can cause acute or chronic infections in
a range of hosts from protozoans to plants to humans [1,2]. In
particular, patients with cystic fibrosis (CF) are highly susceptible
to chronic colonization by P. aeruginosa, which is frequently fatal
because of a persistent inflammatory response leading to gradual
decline of lung function [3,4]. In most cases, following a period of
recurrent colonizations, a single strain of P. aeruginosa becomes
predominant and persists for the rest of the patient’s life [5,6].
Genetic adaptation has been shown to play a major role in
successful establishment of long-term chronic P. aeruginosa
infections of CF patients, and natural selection acts on these
bacteria in CF airways to accommodate the fixation of mutations
that cause beneficial phenotypic changes [7,8,9]. The selected
phenotypes display traits that differ from those of environmental
isolates but are common in populations found in CF patients,
suggesting repeatable patterns of long-term adaptation to the CF
lung [10,11,12].
A trait frequently observed in chronic infections is an increased
mutation rate leading to a mutator phenotype [13,14]. P.
aeruginosa from chronically infected CF airways was the first
natural model to reveal a high proportion of mutators in contrast
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to reported proportions in acute infections [13]. Hypermutability
in CF P. aeruginosa is due primarily to inactivation of the
mismatch repair system (MRS) through lost function of the
antimutator mutS and mutL genes [15], and 36–54% of CF
patients have been shown to be infected by mutator isolates
[13,16,17,18,19]. Theoretical and experimental approaches have
attempted to explain the selection of MRS-mutators as the result
of co-selection (hitchhiking) with linked beneficial mutations
[20,21,22,23,24,25], and their overrepresentation as a conse-
quence of high recombination rates [26]. Mutators have been
linked to the development of antibiotic resistance both in vitro and
in vivo [13,27,28,29,30,31], and have been reported to enhance
genetic adaptation to CF airways through increased accumulation
of new mutations [32]. However, comparisons between mutators
and normo-mutators did not reveal any association between
hypermutability and a particular distribution of mutations among
genes, even for antibiotic resistance-related genes [32]. No study to
date has linked hypermutability in CF adaptation to any specific
adaptive mutation [17,32,33], nor to any key adaptive trait in the
transition to a chronic state of infection [33].
Our previous studies demonstrated a role of MRS deficiency in
the acquisition of CF-related phenotypes under in vitro conditions
such as mucoid conversion [34], lasR inactivation [35,36], and
enhanced adaptability in biofilms [37] – all hallmarks of P.
aeruginosa chronic airway infection. We also reported the ability
of MRS deficiency to bias mutagenic pathways toward DNA
simple sequence repeats (SSRs), which gave specific mutational
spectra under both in vitro [34,38] and in vivo conditions [18,39].
In view of the widespread effect of hypermutability on the process
of adaptation to the CF lung [32], it is important to elucidate the
evolution of MRS-mutator strains in the course of CF chronic lung
infections.
Previous genome analyses of longitudinally collected P.
aeruginosa from CF patients demonstrated intra-patient genomic
diversity of clonal isolates, suggesting that within-host P.
aeruginosa population dynamics are driven by clonal competition
(clonal interference) and/or niche specialization (adaptive radia-
tion) [18,40,41,42]. To further investigate these processes, Chung
et al. compared the genomes of pairs of randomly selected
contemporary isolates sampled from three chronically infected
adult CF patients, and found that the pairs were differentiated by
1, 54, and 344 SNPs, respectively. In the latter case, both isolates
were mutators [43].
Although mutators are frequently found in CF infections, no
whole-genome studies have focused on the within-host evolution of
mutators. Similarly, diversity of within-patient pathogen popula-
tions is relevant to planning of clinical intervention strategies,
elucidation of transmission networks, and understanding of
evolutionary processes, but no study to date has involved genome
sequencing of a sufficiently large collection of P. aeruginosa
isolates taken from the same patient at the same time point to
facilitate an in-depth analysis of population diversity.
We combined two distinct strategies for a genome-wide analysis
of P. aeruginosa MRS-mutators: (i) a longitudinal analysis of two
separate clonal lineages of mutators obtained from two CF
patients; (ii) a within-host population analysis of a large collection
of isolates obtained from a single sputum sample from each of the
patients, to provide a snapshot of mutator population structure in
the CF lung at a single time point. Whole-genome sequencing of
27 P. aeruginosa isolates allowed us to quantify the nature and
extent of the genomic changes of MRS-mutator clones and
provide a panorama of the high genomic diversity that shapes the
structure of P. aeruginosa mutator populations during long-term
adaptation to the CF airway environment.
Results
P. aeruginosa sample collection
To quantitatively describe the evolutionary processes of MRS-
deficient strains during chronic airway infections, we performed
longitudinal and cross-sectional analyses of clonal P. aeruginosa
isolates collected from two CF patients, referred to here as CFA
and CFD (Figure 1, and Materials and Methods). The cross-
sectional study included 90 isolates obtained from a single sputum
sample from each patient. These large collections were used to
investigate the clonal genomic diversity within mutator popula-
tions in a single host at a single time point. Two different non-
epidemic P. aeruginosa strains were collected from geographically
distant locations, Argentina (CFA) and Denmark (CFD), in which
different therapeutic protocols are applied. We were thus able to
analyze two independent mutator populations whose evolutionary
histories were presumably subjected to common as well as patient-
specific selective pressures.
The collection from CFA included: (i) Two sequential isolates
obtained in 2004 (CFA_2004/01) and 2007 (CFA_2007/01).
These isolates were characterized as MRS-mutators because they
harbored missense mutations in the mutS and mutL genes and
showed increased mutation rate (Table 1 and Text S1). (ii) A
collection of 90 P. aeruginosa isolates obtained from a single
sputum sample in 2010 (CFA_2010).
The collection from CFD included: (i) One normo-mutable
isolate obtained in 1991 (CFD_1991/01). (ii) Two sequential
MRS-deficient mutators from 1995 (CFD_1995/01) and 2002
(CFD_2002/01) (Table 1 and Text S1) that harbored the same
mutS missense mutation [33]. (iii) A collection of 90 P. aeruginosa
isolates obtained from a single sputum sample in 2011
(CFD_2011).
The CFA and CFD collections covered periods of 6 and 20 yrs
in the patients’ lives, respectively. Based on previous studies
indicating a doubling time of 115 min for P. aeruginosa in sputum
Author Summary
Patients with cystic fibrosis (CF) are often colonized by a
single clone of the common, widespread bacterium
Pseudomonas aeruginosa, resulting in chronic airway
infections. Long-term persistence of the bacteria involves
the emergence and selection of multiple phenotypic
variants. Among these are ‘‘mutator’’ variants character-
ized by increased mutation rates resulting from the
inactivation of DNA repair systems. The genetic evolution
of mutators during the course of chronic infection is poorly
understood, and the effects of hypermutability on bacte-
rial population structure have not been studied using
genomic approaches. We evaluated the genomic changes
undergone by mutator populations of P. aeruginosa
obtained from single sputum samples from two chronically
infected CF patients, and found that mutators completely
dominated the infecting population in both patients.
These populations displayed high genomic diversity based
on vast accumulation of stochastic mutations. Our results
are in contrast to the concept of a homogeneous
population consisting of a single dominant clone; rather,
they support a model of populations structured by diverse
subpopulations that coexist within the patient. Certain
genes involved in adaptation were highly and conver-
gently mutated in both lineages, suggesting that these
genes were beneficial and potentially responsible for the
co-selection of mutator alleles.
MRS-Mutator Evolution in CF Infections
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[44], we estimated that ,36,500 and ,91,400 duplication events
occurred between the first and last isolates collected from CFA and
CFD, respectively. Genotypic characterization of the two collec-
tions by various molecular methods (Materials and Methods)
showed that each patient was chronically infected by a single,
unrelated P. aeruginosa clone that persisted throughout the study
period. The hexadecimal codes [45] for the SNP patterns of the
CFA and CFD isolates analyzed are 2C32 and 249A, respectively.
MRS-deficient mutators are prevalent among CFA and
CFD intra-patient P. aeruginosa populations
The proportion of MRS-deficient mutators present in each
patient was determined based on the rifampicin mutation
frequency of the 90 P. aeruginosa isolates of the CFA_2010 and
CFD_2011 panels. All the CFA_2010 isolates showed mutation
frequencies (1.761025–7.661026) consistent with a strong mu-
tator phenotype. Similarly, in the CFD_2011 panel, strong
mutator isolates (1.461025–8.361026) comprised ,94% of the
population. The remaining 6% showed mutation frequencies close
to those observed in the prototypic wild-type normo-mutable
strain PAO1 (361028–161027). These findings were supported by
the observed prevalence of mutators in 90 isolates obtained $6
months later from new sputum samples (CFA_2011 and
CFD_2012); 100% of CFA and 90% of CFD isolates displayed
a strong mutator phenotype. To our knowledge, these are the
highest proportions of mutators reported to date in large intra-
patient populations of P. aeruginosa isolated from CF patients. A
previous study, which analyzed sets of 40 isolates per sputum
sample from 10 CF patients, reported proportions of 27% or less
[8]. These findings indicate that P. aeruginosa can persist in
chronic airway infections without the mutator phenotype, but in
certain CF populations, such as those described here, MRS-
deficient isolates may be prevalent and dominate the entire
infecting population.
Genomic evolution of P. aeruginosa mutator isolates
from CF chronic infections
To analyze the genomic evolution of CFA and CFD P.
aeruginosa mutator lineages, we performed whole-genome
sequencing of 13 CFA and 14 CFD isolates. From the CFA
collection, we selected and sequenced the initial isolate
CFA_2004/01, the intermediate CFA_2007/01, and 11 mutator
isolates chosen randomly from the CFA_2010 population
(CFA_2010/01, CFA_2010/11, CFA_2010/26, CFA_2010/31,
CFA_2010/32, CFA_2010/40, CFA_2010/43, CFA_2010/72,
CFA_2010/78, CFA_2010/82, CFA_2010/87). From the CFD
collection, we selected and sequenced the initial normo-mutable
isolate CFD_1991/01, the intermediate mutators CFD_1995/01
and CFD_2002/01, and 11 isolates from the CFD_2011
population consisting of five normo-mutators (CFD_2011/04,
CFD_2011/11, CFD_2011/45, CFD_2011/57, CFD_2011/95)
and six randomly selected mutators (CFD_2011/27, CFD_2011/
28, CFD_2011/33, CFD_2011/34, CFD_2011/83, CFD_2011/
94). The reads of CFA_2004/01 and CFD_1991/01 were
assembled de novo, yielding genomes of 6,294,248 bp and
6,313,855 bp, respectively (Table S1), which were used as
references in subsequent analyses. The sequences of the remaining
Figure 1. Isolate sampling points and patient life spans. P.
aeruginosa isolates were collected from two CF patients: CFA and CFD.
Hollow symbols: single bacterial isolates. Solid circles: cross-sectional
populations of 90 bacterial isolates. *: estimated start of chronic
infection. Gray bar: patient life span.
doi:10.1371/journal.pgen.1004651.g001
MRS-Mutator Evolution in CF Infections
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CFA and CFD isolates were aligned against the corresponding
references to assess the genetic changes accumulated in the two
mutator lineages during the infection process (Table S2).
Both lineages accumulated a high number of mutations during
their evolution in CF airways in comparison with previously
reported normo-mutable CF isolates such as the DK2 and PA14
clones [18,40]. The CFA collection had a total of 2,578 single-
nucleotide polymorphisms (SNPs) and 544 1- to 10-bp insertion/
deletion mutations (microindels). The CFD collection had a total
of 5,710 SNPs and 1,078 microindels (Table S3). We applied
Bayesian statistical analysis to infer time-measured phylogenies
[46], resulting in estimated mutation rates of 106 SNPs/yr
(4.261029 SNPs/bp per generation) for CFA and 89 SNPs/yr
(3.261029 SNPs/bp per generation) for CFD. These findings
indicate a mutation rate ,40-fold higher than that (2.6 SNPs/yr)
reported previously for normo-mutable isolates obtained from CF
chronic infections [18].
Genetic diversity generation in P. aeruginosa intra-patient
mutator populations
SNPs were used as phylogenetic markers to perform a
maximum-parsimony reconstruction of the evolutionary relation-
ship of CFA and CFD isolate groups, and to evaluate temporal
changes in their population genetic structure (Figure 2). Alleles of
P. aeruginosa reference strain PAO1 were used to root the trees.
In both cases, essentially all SNPs (.99.5%) supported single
phylogenetic trees. Interestingly, high genetic diversity was
observed in both CFA and CFD P. aeruginosa intra-patient
populations. CFA_2010 and CFD_2011 contemporary clones
were grouped together into three and four distinguishable clusters,
respectively: Clusters II, III, and IV for CFA (Figure 2A) and
Clusters I, IV, V, and VI for CFD (Figure 2B) trees. Clusters were
composed of genetically similar isolates, whereas more extensive
genetic dissimilarities were observed between clusters. The branch
lengths among clusters differed substantially, indicating uneven
mutational loads in coexisting P. aeruginosa intra-patient popu-
lations.
All CFD normo-mutable isolates were grouped together in
Cluster IV (Figure 2B). In spite of the normo-mutable phenotype,
this cluster shared common branches with the intermediate
mutator isolates CFD_1995/01 and CFD_2002/01 and with
their contemporary mutator clones (branches D, F, and H)
(Figure 2B). These findings suggest that the normo-mutators arose
from a mutator population of branch J at some point. Cluster IV
showed the highest accumulation of mutations during the infection
process, despite the low mutation frequencies of its members
(Figure 2B and Table S3).
The estimated time points of the most recent common ancestor
(MRCA) of the CFA and CFD populations were 2002 and 1988,
respectively. Interestingly, each of these estimates coincided with
Figure 2. Evolutionary relationships among isolates from CFA and CFD lineages. Maximum-parsimony phylogenetic trees of CFA (A) and
CFD (B) were constructed based on the accumulation of new SNPs relative to ancestors CFA_2004/01 and CFD_1991/01. Alleles of P. aeruginosa
reference strain PAO1 were used to root the trees. Lengths of branches are proportional to the number of accumulated SNPs. Branches are
designated by capital letters. MRCA: most recent common ancestor.
doi:10.1371/journal.pgen.1004651.g002
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the year at which the patient was diagnosed as chronically infected
(Figure 1). This finding indicates that the divergent sub-lineages
coexisted for many years – the same as the colonization period of
the patient (Figure 2).
The question arose whether the genetic diversity observed in the
two CF intra-patient populations was associated with differing
repertoires of mutated genes among contemporary isolates, or
whether most mutations occurred in common genes among the
clones. To distinguish between these possibilities, we first
determined the set of genes of each CFA and CFD isolate that
were altered by nonsynonymous SNPs and microindels. Minimum
Spanning Trees (MSTs) were then constructed to illustrate the
relationships among contemporary isolates and their correspond-
ing ancestors based on the number of distinctive mutated genes.
The CFA_2010 intra-patient P. aeruginosa mutator population
(Figure 3A) was distributed in three main clusters, whereas the
CFD_2011 population (Figure 3B) showed four clusters with all
normo-mutable isolates grouped together. The structures of the
two MSTs indicate high genetic diversification and a scenario in
which even contemporary CFA and CFD mutator populations
diversified through mostly different evolutionary pathways.
Pathoadaptive genes and evidence for parallel evolution
in mutator populations
We classified the SNPs according to their distribution in coding
and noncoding regions and their effect in translation, to assess the
selective forces acting on the CFA and CFD P. aeruginosa
lineages. Most of the SNPs in CFA and CFD were found to occur
within coding regions, and 58.0% and 60.2% (respectively)
corresponded to missense mutations (Figure S1). The rates of
nonsynonymous to synonymous mutations (dN/dS) were 0.68 for
CFA and 0.79 for CFD lineages. Thus, most of the SNPs that
became fixed in the P. aeruginosa mutator lineages were neutral
mutations, with most of each genome showing a signature of
purifying selection and/or genetic drift (dN/dS,1; P= 5.2610256
and P= 1.5610247, respectively).
However, it is conceivable that positively selected genes remain
‘‘hidden’’ among the much larger number of genes that have
accumulated mutations by genetic drift. Evolving populations of P.
aeruginosa presumably accumulate adaptive mutations in re-
sponse to the human host environment in which they propagate.
We would therefore expect to observe parallelism in the adaptive
genetic routes of the different lineages. To confirm such
convergent evolution, we attempted to identify genes that
underwent parallel mutation in the 10 sub-lineages (four CFA
sub-lineages and six CFD sub-lineages) that coexisted over many
years (Figure 2). We analyzed our dataset by selecting those genes
that were independently mutated in at least half of the parallel
evolving sub-lineages (see Materials and Methods). Forty genes
were found to be frequently mutated across the sub-lineages
(Table 2), suggesting that the parallel mutation of these genes was
due to positive selection for mutations. Consistently, the signature
for selection for SNPs accumulated in the 40 genes (dN/dS = 0.97)
was significantly higher than the ratio obtained for SNPs affecting
all other genes (dN/dS = 0.75; P= 0.029 by Fisher’s exact test),
suggesting that these mutations were positively selected during
evolution. Analysis of the 40 genes was further focused on those
that were non-synonymously mutated in at least half of the 10 sub-
lineages (Figure 4). Several of these genes were associated with
functions related to CF host adaptation. In particular, ftsI, ampC,
fusA1, mexY, PA1874, and PA0788 are involved in resistance to
antibiotics commonly used in CF therapies, i.e., betalactams,
aminoglycoside, quinolones, chloramphenicol, trimethoprim, and
imipenem [29,47,48,49,50,51,52,53]. Even though the GacA/
GacS system is required for activation of genes involved in chronic
persistence, gacS mutants are prone to generate stable and stress-
tolerant small colony variants (SCVs) when growing in biofilms,
exposed to stress factors [54,55], or in vivo [56], suggesting that
the absence of GacS may confer some additional advantage for
persistence in the CF lung. fusA1 encodes the elongation factor
EF-G1A, which confers resistance to the antibiotic argyrin in P.
aeruginosa [57,58]. Chung et al. recently reported independent
fusA1 mutations in two CF patients and suggested that these
mutations are involved in regulation of virulence through a
ppGpp-dependent stringent response [43]. On the other hand, the
gene pslA is involved in biofilm formation [59], and cupC3 is
associated with motility/attachment [60]. Lack of motility is a trait
frequently observed in isolates from chronically colonized patients,
and may give P. aeruginosa a survival advantage in chronic CF
infection by enabling it to resist phagocytosis and conserve energy
[61].
Alterations in several genes related to bacterial catabolism (e.g.,
aceE, gcvP1, soxA, xdhB, PA0794) were also observed, suggesting
that the inactivation of certain metabolic functions may be a
common trait related to CF host adaptation (see below).
The concurrent alteration of specific genes or functions related
to adaptation to the CF airway environment provides strong
evidence for parallel evolution not only across CFA and CFD
lineages, but also across intra-patient coexisting sub-lineages.
Certain genes were convergently but exclusively mutated among
CFD sub-lineages, e.g., ampC (beta-lactamase precursor), PA0788
(penicillin binding protein), and PA3271 (two-component sensor).
These findings suggest the occurrence of in-host parallel evolu-
tionary processes resulting from specific selective pressures from
differential antibiotic treatments.
Mutations in the global regulators mucA, algT, rpoN, and lasR
are related primarily to adaptation to the CF airway environment
[10,17,33,62,63,64]. However, our analyses did not reveal such
mutations because they arose in the ancestral isolates before
diversification into sub-lineages (Table S4). The entire population
from CFA had a mutation in mucA, whereas the population from
CFD had mutations in lasR and rpoN (Table S4). These findings
indicate that mutations in these regulator genes were specifically
fixed in the respective bacterial populations during early in-host
evolution.
Accumulation of mutations in MRS genes and the
emergence of a subpopulation with reduced mutation
rate
MRS genes in the CFA panel. To investigate the molecular
basis for the strong mutator phenotypes observed in CFA_2010
and CFD_2011 clones, we analyzed the sequences of the MRS
genes mutS and mutL from the whole-genome sequence data and
looked for potential alterations.
Mutations in both MutS (T247P) and MutL (H469R) proteins
were found in the ancestral isolate CFA_2004/01 (Table 1). This
same combination of mutations (termed allelic combination SL1)
was also present in the later isolate CFA_2007/01 and in seven of
the 11 CFA_2010 clones. The remaining four CFA_2010 isolates
showed two additional missense mutations in MutS (L794P and
W160R) and one in MutL (L389S). These two new MRS allelic
combinations were termed SL2 and SL3, respectively (Table 1).
SL1, SL2, and SL3 were distributed in different phylogenetic
clusters (Clusters I, IVa, and IVb for SL1, Cluster II for SL2,
Cluster III for SL3) (Table 1 and Figure 2A), demonstrating the
coexistence of multiple polymorphisms in the MRS genes as a
reflection of the observed genomic diversity.
MRS-Mutator Evolution in CF Infections
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Figure 3. Minimum spanning trees (MSTs) of genomes among CFA and CFD lineages. MSTs for CFA (A) and CFD (B) were constructed
based on the total number of genes altered by nonsynonymous SNPs and indel mutations in the respective genomes. Links between nodes
represents the minimum distance in terms of mutated genes. Numbers above each link indicate the total amount of mutated genes between the two
connected nodes (Table S6). For tree construction, ancestors CFA_2004/01 and CFD_1991/01 were considered as origins.
doi:10.1371/journal.pgen.1004651.g003
MRS-Mutator Evolution in CF Infections
PLOS Genetics | www.plosgenetics.org 7 October 2014 | Volume 10 | Issue 10 | e1004651
Table 2. Evidence for parallel evolution. Genes identified as being independently mutated in at least a half of the coexisting CFA I–
IV and CFD I–VI sub-lineages.
Gene ID Gene name Function classificationa
Total number of
independent mutations
Number of sub-lineages
convergently mutated
CFA CFD
PA3327 Adaptation, Protection 5 2 3
PA4110 ampC 6 1 5
PA0074 ppkA Adaptation, Protection; Translation, post-translational
modification, degradation; Protein secretion/export apparatus
5 2 3
PA5015 aceE Amino acid biosynthesis and metabolism; Energy metabolism 5 2 3
PA5418 soxA Carbon compound catabolism 5 1 4
PA4418 ftsI Cell division; Cell wall/LPS/capsule 6 1 5
PA2231 pslA Cell wall/LPS/capsule 5 1 4
PA2238 pslH 5 1 4
PA5213 gcvP1 Central intermediary metabolism; Amino acid biosynthesis
and metabolism
5 1 4
PA4285 recC DNA replication, recombination, modification and repair 5 2 3
PA0794 Energy metabolism 5 2 3
PA1613 Membrane proteins 6 4 2
PA2072 5 3 2
PA3234 Membrane proteins; Transport of small molecules 5 2 3
PA3920 5 1 4
PA4719 5 3 2
PA0994 cupC3 Motility & Attachment 6 3 3
PA1099 fleR Motility & Attachment; Transcriptional regulators;
Two-component regulatory systems
5 1 4
PA1523 xdhB Nucleotide biosynthesis and metabolism 5 2 3
PA3763 purL 7 4 3
PA3895 Transcriptional regulators 5 2 3
PA4937 rnr Transcription, RNA processing and degradation 5 2 3
PA4266 fusA1 Translation, post-translational modification, degradation 9 4 5
PA2018 mexY Transport of small molecules; Membrane proteins; Antibiotic
resistance and susceptibility
7 3 4
PA0928 gacS Two-component regulatory systems 6 1 5
PA1336 5 2 3
PA3271 6 0 6
PA2378 Putative enzymes 6 2 4
PA4513 6 1 5
PA4489 magD Hypothetical, unclassified, unknown; Adaptation, protection 6 2 4
PA1874 Hypothetical, unclassified, unknown; Antibiotic resistance and
susceptibility
8 3 5
PA1669 Hypothetical, unclassified, unknown; Membrane proteins 5 1 4
PA0454 Hypothetical, unclassified, unknown 6 2 4
PA0788 5 0 5
PA2077 5 1 4
PA2151 5 2 3
PA2635 5 1 4
PA3728 5 2 3
PA4735 5 3 2
PA4836 5 1 4
aThe categories used for functional classification were as described in the The Pseudomonas aeruginosa Community Annotation Project (http://www.pseudomonas.
com).
doi:10.1371/journal.pgen.1004651.t002
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We further sequenced the mutS and mutL genes in 19
additional CFA_2010 isolates to extend our analysis to 30% of
the population (30 isolates). Fourteen of these newly sequenced
isolates carried the ancestral SL1 combination, five carried SL3,
and none carried SL2, leading to final prevalences of 70% for SL1,
3% for SL2, and 27% for SL3. These observations suggest that
SL1 was predominant and persisted over time among the within-
patient coexisting isolates.
The logical next question was whether the different mutations
observed in mutS and mutL in CFA_2010 isolates were able to
alter the function of their respective gene products, resulting in the
mutator phenotype. To address this point, we attempted to restore
a wild-type normo-mutable phenotype from SL1, SL2, or SL3
mutator strains by complementation with a plasmid carrying the
wild-type mutS or mutL gene (Materials and Methods). Our results
indicated that the ancestral mutation in MutL (H469R), but not
those in MutS, was responsible for the mutator phenotype
observed in isolates that carried not only the SL1 combination
but also SL2 and SL3 (Text S1). Although mutS has been shown to
be the main target for acquisition of a stable hypermutor
phenotype [15,65], mutations in mutL are a frequent cause of
MRS deficiency in P. aeruginosa CF isolates [17,66].
MRS genes in the CFD panel. Analysis of the CFD mutator
collection revealed that every CFD_2011 isolate, whether
mutator or normo-mutator, harbored the same ancestral
frameshift mutation in mutS (2CG1551) (Table 1). The normo-
mutable isolates (grouped in Cluster IV) also harbored a +CC334
insertion (Table 1) in a 5-bp G:C simple sequence repeat (SSR)
of mutS. This insertion generates a premature stop codon at
position 347 bp from the ATG start codon. In addition, the +
CC334 insertion produced an ATG codon at 1822 bp, resulting
in restoration of the frameshift now coding for a C-terminal
peptide of 248 amino acids, which correspond to MutS
functionally essential domains [67,68] (File S1). This finding
suggested that the +CC334 insertion is associated with the
reduced mutation frequency in normo-mutators. To test this
concept, we cloned the mutS+CC3342CG1551 allele into the pMC5
plasmid (Table S5) and performed complementation assays in
mutS-deficient strain PAO1 (Materials and Methods). Nonethe-
less, the above allele did not revert the mutator phenotype, and
we found no extra copies of a functional mutS allele in the
normo-mutable genomes.
We next examined the mutational spectra of CFD_2011 isolates
in Cluster IV. The proportion of transversions showed a significant
increase (P#0.05 in two-tailed T-test adjusted by Bonferroni
correction), from 5.8% in contemporary mutators belonging to
Cluster V and VI (with the ancestral mutS2CG1551 allele) to 10.6%
in normo-mutators grouped in Cluster IV (with the
mutS+CC3342CG1551 allele) (Figure S2).
We sequenced the mutS gene in 19 additional CFD_2011
mutator isolates (similarly to the studies of the CFA population)
and found that all of them (100%) carried the 2CG1551 mutation
in mutS, indicating that the proportion of clones with reduced
mutation frequency remains low in the CFD population (,6%).
Figure 4. Pathoadaptive genes convergently mutated in CFA and CFD sub-lineages. The analysis was performed based only on non-
synonymous mutated genes that were altered independently in at least half of the 10 evolving sub-lineages CFA I–IV and CFD I–VI.
doi:10.1371/journal.pgen.1004651.g004
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Mutational snapshot of SSRs in P. aeruginosa mutator
populations
Our previous in vitro studies showed that, in a MRS-deficient
background, G:C SSRs constitute hotspots capable of biasing
mutagenesis toward a specific genetic pathway [34,38]. Our recent
studies of P. aeruginosa PACS2 and epidemic DK2 strains
demonstrated the same phenomenon at a genome-wide level in
CF in vivo chronic airway infection [18,39].
The present study design allows examination of such a genome-
wide effect of biased mutagenesis in large populations obtained at
single time points, and observation of SSR instability in coexisting
isolates.
Analysis of types of mutations occurring in both the CFA_2010
and CFD_2011 isolates revealed a mutational spectrum typical of
MRS-deficient strains. Transitions (,80%) and small indels (1–
4 bp) (,16%) were the most frequently observed mutations in
both collections (Figure 5C). The most prevalent transition was
G:CRA:T, accounting for 65% and 62% of total transitions in
CFA and CFD lineages, respectively. Of the 1–4 bp indels,.80%
were located within a homopolymeric SSR, and ,75% were
located specifically in G:C SSRs (Figure 5A). In contrast, indels in
A:T SSRs accounted in average for 5.2% and 6.7% of the 1–4 bp
indels in CFA and CFD isolates, respectively (Figure 5A).
Based on this strong skewing of MRS spectra toward small
indels in G:C SSRs, we selected homopolymeric G:C SSRs of $
6 bp, which were mutated in at least half of the coexisting isolates
in both CFA and CFD lineages, and analyzed their mutational
dynamics at the intra-population level. Eleven of these highly
mutated G:C SSRs harbored 2–5 distinct indel mutations
accounting for independent mutational events (Figure 5B). A
single SSR was observed to be either unaltered or modified by
different indel mutations even in coexisting isolates from the same
cluster. Analysis of these 11 G:C SSRs in the normo-mutable
CFD_1991/01 isolate showed no mutations. Using genome data
available online, we evaluated the occurrence of indel mutations in
these G:C SSRs in 12 normo-mutable P. aeruginosa strains
(PAO1, PA14, M18, NCGM2.S1, B136-33, RP73, 39016,
PACSC2, 2192, C3719, DK2, LESB58; the latter five are
normo-mutable isolates obtained from CF infections), whose
genomes have been sequenced and are available in the Pseudo-
Figure 5. Mutational spectra and top mutated homopolymeric G:C SSRs in CFA_2010 and CFD_2011 contemporary isolates. (A)
Percentage of 1–4 bp insertions/deletions located in G:C and A:T homopolymeric sequences. (B) The heat map represents individual indels mutations
in homopolymeric G:C SSRs of $6 bp, which were mutated in at least half of the coexisting isolates in both CFA and CFD lineages. The color-code
indicates the type of mutation. Right: Percentage of MRS-deficient isolates harboring a indel mutation in each analyzed G:C SSR. (C) Mutations in
CFA_2010 and CFD_2011 isolates were analyzed based on the percentage of transitions, transversions, and insertions/deletions.
doi:10.1371/journal.pgen.1004651.g005
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monas Genome Database (www.pseudomonas.com) [69]. Our
survey revealed that these 12 strains harbored no indel mutations
in the analyzed G:C SSRs, even though large G:C SSRs are
considered to be ‘‘hotspots’’ for mutagenesis.
One of the identified homopolymers is located in a gene
(PA4071/PADK2_03970) which has been previously suggested to
be preferentially mutated in mutators and to represent a mutator-
specific target of adaptive mutations [18].
These findings suggest a scenario in which MRS-deficient
populations generates a vast of genetic diversity due to G:C SSR
instability. In this scenario, genes containing large G:C SSRs
constitute continual sources of genetic diversification primarily in
mutator bacterial populations.
Global analysis of the catabolic capacities of CFA and
CFD mutator lineages during long-term evolution in CF
infections
We evaluated the dynamics of phenotypic changes in the 27 P.
aeruginosa CFA and CFD isolates by determining global catabolic
activities (the ‘‘catabolome’’). Biolog phenotype microarrays were
used to monitor the catabolic profiles of each isolate with various
C and N sources (Table S7). The total catabolic functions in the
isolates were greatly reduced (average reduction 73.5% and
63.8%, respectively) in comparison with those of the CFA_2004/
01 and CFD_1991/01 ancestors (Figure 6). This extensive loss of
functions led to homogeneous populations in both the CFA and
CFD lineages, with slight catabolome variation among clones.
Catabolic function reduction thus appears to be a phenotypic
pattern shared by CFA and CFD mutator lineages. Accordingly,
genes related to catabolism were convergently mutated in both the
CFA and CFD lineages (Figure 4). This phenomenon may be
partially responsible for the decreased catabolic phenotype.
Discussion
This study provides a complete panorama of the genomic
diversity that shapes the structure of P. aeruginosa mutator
populations during long-term adaptation to the CF airway
environment. We combined a longitudinal study with an extensive
cross-sectional approach, including multiple isolates obtained from
single sputum samples, which allowed in-depth analysis of
population diversity (Figure 1). We utilized P. aeruginosa panel
collections from two chronically infected CF patients, CFA
(Argentinian) and CFD (Danish), with time spans of 6 yrs and
20 yrs, respectively, from initial to later stages of chronic infection.
Our comprehensive study design included whole-genome se-
quencing and high-throughput phenotypic approaches, calculation
of mutation frequencies, phylogenetic estimation of time points of
sub-lineage diversification, and analysis of mutS and mutL genes to
obtain a wide-ranging depiction of hypermutability in CF.
We expected (and confirmed) that each of the two patients was
infected by a single non-epidemic P. aeruginosa clone that did not
present, during the initial stages of infection, the pathoadaptive
mutations displayed by epidemic clones [42,70,71,72]. We were
therefore confident that our analysis addressed specific and
independent in-host evolutionary processes. Mutator strains were
highly prevalent in both patients, essentially dominating the
populations. The proportion of mutators was $90% in the single
time point 90-isolate collections, indicating that mutators, once
selected, dominated the CFA and CFD infecting populations. The
observed prevalence of within-patient mutators was much higher
than the values reported in previous studies [8,13]. These findings
indicate that although P. aeruginosa may persist throughout the
course of chronic infection without ever acquiring the mutator
phenotype, mutator strains may become prevalent and even
dominate the whole population under certain yet-unknown
conditions. This concept is supported by the observation that
two patients of different ages from geographically distant locations,
infected with different non-epidemic P. aeruginosa clones and
subjected to different therapeutic protocols, underwent overlap-
ping evolutionary trajectories that led to complete domination of
mutators.
Recent reports have demonstrated high diversity at the
phenotypic level among P. aeruginosa populations from CF lung
infections [8,9,73]. However, there have been no genome-wide
studies of such diversity in bacterial populations from the same
clinical samples. The global picture of genetic structure of intra-
patient mutator populations in the present study reveals significant
Figure 6. Average total catabolic function of isolates from CFA and CFD lineages. Total catabolic function was calculated relative to
CFA_2004/01 and CFD_1991/01 as a weighted average across all substrates for each CFA (A) and CFD (B) isolate. Total catabolic function was defined
as 1 for the reference levels (CFA_2004/01 and CFD_1991/01). Lower values indicate decay. Isolates CFA_2010/01, CFA_2010/11, and CFA_2010/31
were excluded from the analysis because significant dispersion was observed in the duplicates.
doi:10.1371/journal.pgen.1004651.g006
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genomic diversity driven by high accumulation of mutations
(Figures 2 and 3), reflected by the typical MRS spectra (Figure 5).
The distribution and combination of thousands of mutations result
in a unique genotype for every isolate, allowing long-term
persistence in the CF airway environment. The observed genomic
variation into the CFA and CFD lineages indicates that the
population structure in each case was not determined by
homogeneous single dominating clones, but occurred through
multiple evolutionary genetic pathways that adapted equally to the
CF airway environment and allowed the coexistence of diverse
subpopulations for many years. We determined that this high
genomic diversity, to an equal degree in the two patients, spread
out from the establishment of chronic infection. Interestingly,
MRS genes were also characterized by the coexistence of multiple
polymorphisms. However, underlying the polymorphisms within
the MRS genes, there is an ancestral mutation that was fixed in
each CFA and CFD population and is apparently responsible for
hypermutability. These findings suggest the existence of common
selective forces acting on MRS inactivation in the two patients.
The long-term evolution of the P. aeruginosa CFA and CFD
lineages was signed mainly by purifying selection and/or genetic
drift. There are conflicting reports regarding whether genomic
evolution of CF isolates shows signatures of positive selection [10]
or (in contrast) genetic drift and/or purifying selection [32]. Our
results strongly support the latter concept; i.e., that genomic
signatures of purifying selection and/or genetic drift are not
inherent consequences of mutators, but are characteristic of the
genetic adaptation processes underlying P. aeruginosa persistence
in chronic lung infections.
According to our observations, the large number of mutations
were for the most part distributed randomly among the P.
aeruginosa mutator genome (Figure 3). However, we also
identified a group of genes that were convergently mutated in
multiple genomes by independent mutational events (Table 2 and
Figure 4). Most of these genes code for functions related to
pathogenicity (e.g., antibiotic resistance, virulence, motility,
attachment), suggesting that they were positively selected as
beneficial mutations. We note that five of the genes (ampC, ftsI,
fusA1, PA3271, PA2018) were also found to be mutated in isolates
obtained from the epidemic DK2 clone [18], providing evidence
of parallel evolution for certain specific traits among different P.
aeruginosa lineages.
As we have reported recently for the PACS2 [39] and epidemic
DK2 P. aeruginosa strains [18], the impact of hypermutability on
the evolution of the CFA and CFD lineages is reflected by the high
tendency of G:C SSR-containing sequences to be mutated
(Figure 5A). This finding confirms that genes which maintain
G:C SSRs in their coding region and/or in neighboring regulatory
sequences are highly unstable in an MRS-deficient background
and may be mutator-specific targets of adaptive mutations. This
concept is extended here by the demonstration that large G:C
SSRs, as DNA sequences per se, are highly polymorphic in single
time point populations, indicating that they are continual sources
for diversification (Figure 5B). This SSR-driven diversity is not
observed in genomes of other P. aeruginosa strains, even of
normo-mutable CF clones. Our present and previous results
[18,34,38,39], taken together, demonstrate a clear association
between MRS-deficiency and G:C SSR instability, which exerts a
global effect along the entire genome. The impact of hypermu-
tability during evolution of P. aeruginosa in the CF airway
environment is not simply a major, rapid acquisition of mutations
in quantitative terms. In contrast with SNPs, indels that are not
multiples of three produce frameshifts in the coding sequence of
genes and thereby affect gene function. Indels in G:C SSRs may
play an important role in the evolutionary process and in relation
to mutator competitiveness. Along this line, nine of the 11
analyzed G:C SSRs (Figure 5B) were located in coding regions of
the genome. Five of these genes are predicted to encode for
hypothetical proteins with no assigned function. On the other
hand, some G:C SSRs were positioned in genes functionally
related to transcriptional regulators (PA1490), adaptation-protec-
tion (PA1127), membrane proteins, and transport of small
molecules (PA1626, PA2203).
A small percentage (6%) of the CFD population has a reduced
mutation frequency similar to that of normo-mutable strains. This
subpopulation, which is grouped in a single cluster (Cluster IV in
Figure 2), had the highest accumulation of mutations observed in
the whole CFD collection (Table S3). This observation posed the
question whether the mutational load of these clones is too heavy
to continue supporting a mutator phenotype. However, the
normo-mutable subpopulation carried the same mutS loss-of-
function mutation (Table 1) as the mutator isolates. Phylogenetic
analysis indicated that isolates from Cluster IV had arisen from a
mutator subpopulation at some undetermined point in branch J
(Figure 2). Our sequencing data suggested that the most feasible
explanation is the emergence of secondary mutations, in genes not
belonging to the MRS, that compensate for mutS hypermutability,
since neither reversion of the original 2CG1551 nor duplication of
the mutS gene was observed in normo-mutable genomes.
Although the new +CC334 mutation restored in part the mutS
reading frame, this fact did not account for the reduction in
mutation frequency observed in these clones. In a previous study,
E. coli MRS-deficient populations in vitro evolved a compensation
of the mutator phenotype based on secondary mutations in genes
related to oxidative stress response which, although selected for
different increasing-fitness traits, resulted in a reduction of the
mutation rate [74]. Future studies will elucidate the mechanisms
underlying the observed reduction in mutation frequency of these
mutS-deficient P. aeruginosa strains.
How are these mutator populations maintained over extended
periods of time, and even able to accumulate greater numbers of
mutations? The chronically infected CF lung is a uniquely
challenging habitat in which P. aeruginosa must cope with
aggressive immune system responses, intense antibiotic therapies,
and/or competition with other resident microorganisms. This
environment presents stressful and variable conditions, and
multiple mutations may occur that increase fitness. On the other
hand, favorable nutritional conditions of CF airways [75,76] may
sustain the inactivation of certain functions that are no longer
necessary for survival, particularly in this environment. In this
regard, CF isolates have been reported to accumulate a high
number of auxotrophies – higher than in other studied environ-
ments [77]. The results obtained here for CFA and CFD
catabolomes indicate overall reduction of total catabolic activities
(Figure 6). Reduction of catabolic functions appears to be part of a
more general adaptive process of P. aeruginosa residing for long
periods in the CF lung, because such reduction has also been
observed in normo-mutable strains [42]. The large genome of P.
aeruginosa may have the potential to undergo reductive evolution,
with elimination of functions that are redundant and/or dispens-
able in the CF host environment, thereby buffering the heavy
mutational load observed [78].
Based on these considerations, we hypothesize that, during long-
term evolution of P. aeruginosa in CF airways, the increased
availability of certain beneficial mutations, in combination with a
whole-genomic signature of neutral evolution, provided favorable
conditions to increase the percentage of mutators, until reaching a
frequency at which mutators dominated both the CFA and CFD
MRS-Mutator Evolution in CF Infections
PLOS Genetics | www.plosgenetics.org 12 October 2014 | Volume 10 | Issue 10 | e1004651
populations. P. aeruginosa adaptation to the CF lung is
presumably manifested through selection of multiple genetic
combinations [79], and hypermutability is consequently main-
tained over time as a constant source of genetic variation.
Materials and Methods
P. aeruginosa isolate collections
Clinical P. aeruginosa isolates were obtained from sputum
samples from two CF patients at the Hospital de Nin˜os Santı´sima
Trinidad (Co´rdoba, Argentina) (patient CFA) and the Copenha-
gen CF Centre at Rigshospitalet (Copenhagen, Denmark) (patient
CFD). Patient age at the time of the first isolate collection was 8
and 23 yrs, respectively. The onset of chronic infection with P.
aeruginosa was 2001 and 1986, respectively. Chronic pulmonary
infection was defined as the persistence of P. aeruginosa in sputum
for 6 consecutive months, or less if the persistence was combined
with presence of two or more precipitating antibodies against P.
aeruginosa [33]. The criteria for choosing these patients were: (i)
chronic airway infection by P. aeruginosa; (ii) absence of
transmissible P. aeruginosa clones; (iii) presence of single clonal
P. aeruginosa infecting lineages throughout the course of
infection; (iv) appearance of MRS-deficient P. aeruginosa
mutators during the course of infection.
Sputum samples were collected by expectoration during routine
hospital visits, stored on ice, and processed immediately. Sputa
were liquefied by addition of an equal volume of Sputolysin
(Calbiochem), diluted, and plated onto Pseudomonas isolation agar
(BD Biosciences), which promotes growth of P. aeruginosa and
other Pseudomonas species. For cross-sectional analysis, 90 isolates
were taken randomly from a single sputum sample. Isolates were
maintained and stored at 270uC in glycerol stock solution. For
assays, isolates were subcultured from the frozen stocks onto Luria
Bertani (LB) agar plates, and inocula were prepared from
overnight cultures in LB broth at 37uC with appropriate aeration.
Genotyping analysis
Genotyping analysis of the P. aeruginosa isolates was performed
by Randomly Amplified Polymorphic DNA (RAPD), using primer
272 (Table S5) [5,80]. Banding patterns from electrophoretic gels
were analyzed by GelPro Analyzer V. 6.3 software. Epidemiolog-
ical relatedness was evaluated by pulsed-field gel electrophoresis
(PFGE) using SpeI enzyme as described previously [81]. DNA
macrorestriction patterns were interpreted according to the
criteria of Tenover et al. [82]; i.e., isolates with PFGE patterns
differing by (i) 1–3 bands are closely related clones; (ii) 4–6 bands
are possibly related clones; (iii) $7 bands belong to different
strains. Clonal relatedness among the isolates selected for genome
sequencing analysis was evaluated by single-nucleotide polymor-
phism (SNP) typing using AT biochips (Clondiag Chip Technol-
ogies, Germany) [83]. Strain assignment was performed by visual
array analysis using a hexadecimal code as described previously
[45].
Mutation frequency measurement
Mutation frequencies were estimated as described previously
[13,15]. In brief, five independent colonies of each isolate were
grown overnight in 10 ml LB medium at 37uC with appropriate
aeration. Cultures were collected by centrifugation at 3000 rpm
for 10 min and resuspended in 1 ml LB medium. Serial ten-fold
dilutions were plated on LB agar with and without 300 mg/ml
rifampicin. After 36 h incubation (48 h for slow-growing strains) at
37uC, colonies were counted and the mean percentage of mutants
was estimated. Strains were considered hypermutable if the
mutation frequency was at least 20-fold higher than that of
control strain PAO1 [13]. Frequencies were determined from two
independent experiments.
Genome sequencing
Genomic libraries were prepared as described previously [42]
and sequenced on an Illumina Hiseq2000 platform, generating
100 base paired-end reads using a multiplexed protocol. A total of
224 million paired-end reads were generated to yield average
genomic coverage of 33–207 fold (all average coverage depths
were $826 except for CFD287_2011/94 (336) and CFD_2011/
27 (526)). Genome sequence reads were deposited in the
European Nucleotide Archive (ENA/SRA ERP002379).
Illumina reads from isolates CFA_2004/01 and CFD_1991/01
were de novo assembled using Velvet software V. 1.2.07 [84] using
the following settings: -ins_length 238 and 244 for CFA_2004/01
and CFD_1991/01, respectively; -ins_length_sd 54.4 and 50.3 for
CFA_2004/01 and CFD_1991/01, respectively; -exp_cov 291.1
and 296.7 for CFA_2004/01 and CFD_1991/01, respectively;
-cov_cutoff 10; -min_contig_lgth 500. Selected kmer sizes were 51
and 39 for CFA_2004/01 and CFD_1991/01, respectively. Each
de novo assembly was used as a reference genome sequence to map
reads from the remaining CFA and CFD genome sequences using
Novoalign V. 2.08.02 (Novocraft Technologies) [85]. Pileups of
the mapped reads were processed by SAMtools V. 0.1.7 [86].
SNPs were identified by the varFilter algorithm in SAMtools
(samtools.pl varFilter -d 3 -D 10000), and only unambiguous SNPs
with quality scores (Phred-scaled probability of sample reads used
as homozygous reference) of $50 (i.e., P#1025) were retained.
Read alignments surrounding all putative indels were realigned
using GATK V. 1.0.5083 [87], and microindels were extracted
from the read pileup using the following criteria: (i) quality score$
500; (ii) root-mean-square (RMS) mapping quality $25; (iii)
support by $20% of the covering reads. The false-negative rates
obtained were 2% and 3% by in silico introduction of random
base-substitutions and microindels (lengths 1–10 bp), respectively.
All sites with putative polymorphisms in the pileup of reads from
the reference were excluded to avoid false-positives resulting from
errors in the reference assembly or general mapping errors.
MUMmer3 [88] was used for whole-genome alignments. Muta-
tions were described according to their relative gene positions in
orthologs of P. aeruginosa reference strains PAO1, PA14, and
LESB58 with completed genome sequences [69]. If no ortholog
was found in the reference strains, the mutation was described
by the GenBank ID of the homolog sequence (Genbank_ID:
ORF_name: Position) or as ‘‘Not annotated’’.
Phylogenetic trees based on the SNP mutations identified in
each alignment were constructed using maximum-parsimony
analysis as described previously [42].
For calculation of selection coefficients (dN/dS ratio), we
assumed that codon usages were identical to those in strain
PAO1, in which 25% of random mutations are synonymous [42],
and that the probability of the observed number of nonsynon-
ymous SNPs, given the expected number of SNPs, is calculated
from the Poisson distribution.
Bayesian evolutionary analysis
Bayesian analysis of evolutionary rates was performed using
BEAST V. 1.7.2 [46]. The BEAST program was run with the
following user-determined settings: a lognormal relaxed molecular
clock model, which allows rates of evolution to vary among the
branches of the tree, and a HKY substitution model, which
distinguishes between the rate of transitions and transversions and
allows unequal base frequencies. Mutation rates were calculated
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from chains of 100 million steps, sampled every 5,000 steps. The
first 10 million steps of each chain were discarded as a burn-in.
Identification of genes subject to convergent evolution
To identify genes subject to convergent evolution, we picked out
those that were mutated in at least half of the in parallel evolving
sub-lineages CFA I–IV and CFD I–VI. The sub-lineages/clusters
were defined as follows (see Figure 2). CFA lineage: Cluster I:
branches Z, Y; Cluster II: branch A; Cluster III: branches C, D, E,
F, G; Cluster IV: branches N, J, T, U, R, S, O, Q, K, I, M. CFD
lineage: Cluster I: branch A2; Cluster II: branch C; Cluster III:
branch E; Cluster IV: branches J, I, L, M, N, K, P, O; Cluster V:
branches U, T, W, V, X; Cluster VI: branches R, G, Q. For
example, gene aceE was hit by independent mutations in CFA
branch J (sub-lineage CFA-IV), CFA branch Y (sub-lineage CFA-
I), CFD branch C (sub-lineage CFD-II), CFD branch E (sub-
lineage CFD-III), and CFD branch T (sub-lineage CFD-V). To
rule out the possibility that high accumulation of mutations
resulted from particularly large gene sizes, mutations from large
genes ($10 kb) were excluded from the analysis.
Minimum spanning trees (MSTs)
MSTs for the set of mutated genes within each CFA and CFD
lineage were obtained using Prim’s algorithm (Prim, 1957) as
implemented in the Info-Gen program [89]. In this model, nodes
represent an isolate’s set of mutated genes, the distance between a
pair of nodes is shown as the number of distinctive mutated
genes, and nodes are connected in such a way that the sum of the
distances is minimized (Table S6).The network connects each
genotype to all other genotypes through a pathway of mutated
genes. The CFA_2004/01 and CFD_1991/01 genomes were
used as starting points of the network of the corresponding MSTs
for each lineage. The number of mutated genes along the
network was used as a measure of divergence between two given
genotypes.
Sequence analysis of the mutS and mutL genes
Genomic DNA of P. aeruginosa CF isolates was extracted using
a DNA Isolation Kit (Qiagen). Primers used for PCR amplification
and DNA sequencing are listed in Table S5. PCR amplifications
were performed with the following conditions: 8 min at 95uC, 33
cycles of 1 min at 94uC, 1 min 20 sec at 60uC, 2 min at 72uC, and
a final extension of 10 min at 72uC. PCR products were cleaned
with a Gel Purification Kit (Qiagen), and both strands were
sequenced directly using the same PCR primers (DNA Sequencing
Facility, Univ. of Chicago, IL, USA). To score mutations within
the gene, sequencing results were compared with the correspond-
ing gene sequence of strain PAO1 (www.pseudomonas.com) using
the BLAST program of the NCBI database (www.ncbi.nlm.
nih.gov/blast/).
Construction of plasmids pMC5-MutS2CG1551 and
pMC5-MutS+CC3442CG1551
Two constructs of plasmid pMC5-MutS [90], which contains
the full coding region of the mutS gene from strain PAO1, were
generated by introducing 2CG1551 and +CC3342CG1551 muta-
tions to produce plasmids pMC5-MutS2CG1551 and pMC5-
MutS+CC3442CG1551, respectively. To introduce these muta-
tions, the mutS genes from CFD_2011/27 and CFD_2011/11
isolates were amplified by PCR using oligonucleotides mutS-for1
and mutS-rev4 (Table S5), ligated to the pGEM-T Easy vector
(Promega), and cloned in the NdeI/EcoRI restriction sites of
pMC5-mutS, in which the mutS gene has been digested with
NdeI/EcoRI. Both plasmids were propagated on E. coli DH5a
(Invitrogen) transformed by heat shock by standard procedures.
Complementation assays with pMC5-MutS, pMC5-MutL,
pMC5-MutS2CG1551, and pMC5-MutS+CC3442CG1551
plasmids
To evaluate the genetic basis of the mutator phenotype,
plasmids pMC5-mutS [90] and pMC5-mutL [91] were succes-
sively transferred into the mutator CFA and CFD isolates. To
analyze +CC3442CG1551 mutations in the mutS gene, plasmids
pMCS-MutS2CG1551 and pMCS-MutS+CC3442CG1551 were
independently transferred into reference strain MPAO1MS. All
plasmids were transferred by electroporation as described by Choi
and Schweizer [92], and transformed strains were selected on LB
agar plates supplemented with 100 mg/ml gentamicin. Comple-
mentation was checked by the rifampin test described above. For
each strain, complementation was confirmed for three indepen-
dent transformed colonies.
Catabolic analysis by Biolog Phenotype MicroArrays
Phenotype MicroArrays PM1 and PM3B (Biolog; Hayward,
CA, USA) were performed according to the manufacturer’s
instructions [93,94]. Export of Omnilog data was performed using
Omnilog OL-FM/Kin software V. 1.20.02 (Biolog). Phenotypes
were determined based on the parameter ‘‘ave area’’ (the area
beneath the respiration curve of reduced tetrazolium vs. time). For
comparison of clinical isolates, data were exported after 72 h
incubation. Data analysis and statistical analysis were performed
using R Project V. 2.10.0 (http://www.R-project.org). The R
packages used for analysis were ‘‘bioDist’’ (B. Ding, R. Gentleman,
V. Carey). Total catabolic function was calculated as described
previously [95].
Statistical analyses
Statistical analyses were performed using a two-tailed T-test
adjusted by Bonferroni correction. Differences with P#0.05 were
considered statistically significant.
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Figure S1 SNP mutations in CFA and CFD lineages. SNPs were
analyzed in terms of percentages of nonsense, missense, silent,
intergenic, and non-annotated SNPs.
(TIF)
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Figure S2 Mutational spectra of CFD normo-mutable and
mutator genomes. SNPs were analyzed in terms of the percentages
of transitions and transversions in Clusters IV (normo-mutators)
and V–VI (mutators). The total number of SNPs from CFD
maximum-parsimony phylogenetic tree branches J-I-L-P-O-N-K-
M and S-U-T-W-V-X-Q-R-G were considered for Clusters IV
and V–VI, respectively (see Figure 2). *: significant difference (P,
0.05).
(TIF)
Table S1 De novo assemblies of P. aeruginosa CFA_2004/01
and CFD_1991/01 genomes.
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Table S2 Illumina sequencing and mapping statistics.
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